Spin Transfer Technologies, a Freemont, Calif.-based maker of MRAM (Magnetoresistive Random Access Memory) technology, has appointed Barry Hoberman as CEO and board chairman. Hoberman joins the firm from the semiconductor company Crocus Technology, where he was chief marketing officer.

Boston-based Spin Transfer Technologies, the developer of computer memory technology, secured a $36 million Series A round. The investment was led by Spin Transfer Tech’s parent company, Allied Minds and Invesco Asset Management. Spin Transfer Tech was established by NYU and Allied Minds. PRESS RELEASE BOSTON–(BUSINESS WIRE)–Spin Transfer Technologies, Inc. a leading developer of a [...]

John Serafini will join Boston-based investment firm Allied Minds, which focuses on commercializing early-stage technologies. Serafini has spent four years as a principal with Good Harbor Consulting, where he worked with Richard Clarke, the former senior White House Advisor. There, Serafini worked as a venture capital/growth equity investor.

Precision Biopsy has closed on $2.5 million from Allied Minds. The funding will help the company with the commercialization phase of its novel prostate cancer detection technology. Precision Biopsy was formed Allied Minds in cooperation with the University of Colorado. Allied Minds is a private equity-funded innovation company with offices in Boston and Los Angeles.

Boston-based Allied Minds led a $10 million round for RF Biocidics Inc., a company that manufactures chemical-free treatment equipment and systems designed to eliminate food related pathogens, pests, and fungi. Existing shareholder Invesco Asset Management Ltd. also contributed to the round, which will be used to expand the company’s proprietary pasteurization and disinfestation businesses.

CryoXtract has closed a $3 million round of funding led by Allied Minds. Arlington, Va.-based CryoXtract develops laboratory automation services for the biobanking community.

SciFluor Life Sciences has raised $5 million from Allied Minds. The first round of funding is designed to support commercialization of its technology to enable late-stage fluorination of pharmaceutical drug candidates and other commercial chemicals. The company’s technology is based on technology developed by Harvard professor Tobias Ritter and his colleagues in the school’s department of chemistry and chemical biology. Allied Minds is a private equity-funded company with offices in Boston and Los Angeles.

SoundCure has closed a $3 million round of funding led by Allied Minds. SoundCure is developing an acoustic therapy to treat tinnitus.

Greg Erman has joined Allied Minds as an entrepreneur-in-residence, with a focus on medical technologies. He most recently served as president and CEO of Novo Medical Corp. Allied Minds is an early-stage VC firm focused on commercializing technologies from U.S. universities and national labs.